Neurodegenerative diseases and color vision impairment: a literature review

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F24%3AA25039LT" target="_blank" >RIV/61988987:17110/24:A25039LT - isvavai.cz</a>

Výsledek na webu

<a href="https://www.termedia.pl/Is-metformin-a-new-weapon-against-cancer-a-literature-review,95,54584,0,1.html" target="_blank" >https://www.termedia.pl/Is-metformin-a-new-weapon-against-cancer-a-literature-review,95,54584,0,1.html</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5114/fmpcr.2024.142014" target="_blank" >10.5114/fmpcr.2024.142014</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Neurodegenerative diseases and color vision impairment: a literature review

Popis výsledku v původním jazyce

Background. Early detection and diagnosis of dementia are of key importance in treatment, slowing disease progression orsuppressing symptoms. Color vision impairment may be observed in some cases in patients with Alzheimer’s disease, and its potentialrole in early diagnosis of neurodegenerative diseases is questioned.Objectives. The aim of this review is to provide up-to-date information on color vision impairment in various neurodegenerative diseases.Material and methods. A literature search was conducted using the electronic databases PubMed, Scopus and Web of Science, and theterm “dementia” was searched with keyword combinations related to color vision.Results. A total of 785 records were identified through database searching, and 25 articles were ultimately included in the analysis.Multiple studies have shown that patients with neurodegenerative diseases and dementia have impaired color vision, and the possiblerole of color vision changes are considered as potential biomarkers for early detection in several cases. The results show that colorvision impairment is being investigated not only in patients with Alzheimer’s disease but also in other neurodegenerative diseases.Conclusions. In individuals with cognitive impairment or neurodegenerative diseases, color vision changes have repeatedly been reported.In some cases, the use of color vision changes for differential diagnosis between certain neurodegenerative diseases hasproved useful. Several authors have agreed that color vision tests could be a possible simple method for early diagnosis of dementia.

Název v anglickém jazyce

Neurodegenerative diseases and color vision impairment: a literature review

Popis výsledku anglicky

Background. Early detection and diagnosis of dementia are of key importance in treatment, slowing disease progression orsuppressing symptoms. Color vision impairment may be observed in some cases in patients with Alzheimer’s disease, and its potentialrole in early diagnosis of neurodegenerative diseases is questioned.Objectives. The aim of this review is to provide up-to-date information on color vision impairment in various neurodegenerative diseases.Material and methods. A literature search was conducted using the electronic databases PubMed, Scopus and Web of Science, and theterm “dementia” was searched with keyword combinations related to color vision.Results. A total of 785 records were identified through database searching, and 25 articles were ultimately included in the analysis.Multiple studies have shown that patients with neurodegenerative diseases and dementia have impaired color vision, and the possiblerole of color vision changes are considered as potential biomarkers for early detection in several cases. The results show that colorvision impairment is being investigated not only in patients with Alzheimer’s disease but also in other neurodegenerative diseases.Conclusions. In individuals with cognitive impairment or neurodegenerative diseases, color vision changes have repeatedly been reported.In some cases, the use of color vision changes for differential diagnosis between certain neurodegenerative diseases hasproved useful. Several authors have agreed that color vision tests could be a possible simple method for early diagnosis of dementia.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30103 - Neurosciences (including psychophysiology)

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2024

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Family Medicine & Primary Care Review

ISSN

1734-3402

e-ISSN

2449-8580

Svazek periodika

—

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

PL - Polská republika

Počet stran výsledku

13

Strana od-do

389-401

Kód UT WoS článku

001336389300015

EID výsledku v databázi Scopus

2-s2.0-85206264948